Cargando…

New therapeutic options for HCV in Central Europe

New therapeutic options became available in 2015 in the European Union. We present the availability of interferon-free regimens with direct acting antivirals (DAA) in four Central European countries – the Czech Republic, Hungary, Poland and Slovakia – which despite similar historical, geographical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flisiak, Robert, Urbánek, Petr, Rokusz, Laszlo, Oltman, Marian, Makara, Mihaly, Janicko, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497412/ https://www.ncbi.nlm.nih.gov/pubmed/28856265 http://dx.doi.org/10.5114/ceh.2016.58850

Ejemplares similares

Epidemiology of HCV infection in the Central European region
por: Urbánek, Petr, et al.
Publicado: (2016)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

How close are we to hepatitis C virus elimination in Central Europe?
por: Flisiak, Robert, et al.
Publicado: (2020)

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy
por: Hunyady, Béla, et al.
Publicado: (2018)

Perspectives of hepatitis C virus (HCV) elimination in Poland
por: Flisiak, Robert, et al.
Publicado: (2019)

Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures
por: Flisiak, Robert, et al.
Publicado: (2021)

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020
por: Halota, Waldemar, et al.
Publicado: (2020)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Grubczak, Kamil, et al.
Publicado: (2021)

Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland
por: Grzeszczuk, Anna, et al.
Publicado: (2015)

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2023)

The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation
por: Łapiński, Tadeusz W., et al.
Publicado: (2016)

Cyclosporine as Monotherapy for Psoriasis in the Setting of Chronic HCV Infection: A Forgotten Therapeutical Option
por: Giovanna Brunasso, Alexandra Maria, et al.
Publicado: (2012)

Real-world experience with ombitasvir/paritaprevir boosted with ritonavir and possibly combined with dasabuvir and ribavirin in HCV infection
por: Pogorzelska, Joanna, et al.
Publicado: (2016)

Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central Asia
por: Kazatchkine, Michel
Publicado: (2014)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
por: Turkova, Anna, et al.
Publicado: (2015)

Liver transplantation in Central Europe
por: Trunecka, Pavel, et al.
Publicado: (2016)

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland
por: Chlabicz, Slawomir, et al.
Publicado: (2011)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Vulvar leukoplakia: therapeutic options
por: Yordanov, Angel, et al.
Publicado: (2020)

Impact of rs12979860 polymorphism on liver morphology in chronic HCV infection
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2015)

Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
por: Huss, Michael, et al.
Publicado: (2015)

Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis
por: Maasoumy, Benjamin, et al.
Publicado: (2014)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
por: Wasitthankasem, Rujipat, et al.
Publicado: (2017)

Exploring and understanding HCV patient journeys- HEPCARE Europe project
por: Glaspy, Shannon, et al.
Publicado: (2021)

Therapeutic options for severe asthma
por: Mathew, Jilcy, et al.
Publicado: (2012)

Antiviral resistance in HCV strains isolated from Romanian patients with limited treatment options for chronic HCV infection
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts – 2015
por: Halota, Waldemar, et al.
Publicado: (2015)

Expression of Biliverdin Reductase A in Peripheral Blood Leukocytes Is Associated with Treatment Response in HCV-Infected Patients
por: Subhanova, Iva, et al.
Publicado: (2013)

Editorial: Advances in Primary Immunodeficiency in Central-Eastern Europe
por: Pac, Malgorzata, et al.
Publicado: (2021)

Current therapeutics against HCV
por: Bhattacharjee, Chayan, et al.
Publicado: (2021)

Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals
por: Flisiak, Robert, et al.
Publicado: (2023)

Adaptation options for wheat in Europe will be limited by increased adverse weather events under climate change
por: Trnka, Miroslav, et al.
Publicado: (2015)

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts – 2016
por: Halota, Waldemar, et al.
Publicado: (2016)

Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives
por: Major, Marian E.
Publicado: (2009)

Laparoscopic Reduction of Intussusception: an Evolving Therapeutic Option
por: Burjonrappa, Sathyaprasad C.
Publicado: (2007)

Acquired facial lipoatrophy: pathogenesis and therapeutic options
por: Szczerkowska-Dobosz, Aneta, et al.
Publicado: (2015)

Mytilus trossulus in Northern Europe
por: Väinölä, Risto, et al.
Publicado: (2011)

Prevalence of HCV genotypes in Poland – the EpiTer study
por: Flisiak, Robert, et al.
Publicado: (2016)

New Therapeutics Options for Pediatric Neuromuscular Disorders
por: Flotats-Bastardas, Marina, et al.
Publicado: (2020)

New Therapeutic Options for Advanced Hepatocellular Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5j8h6fq6dtka1tnakv17thl8jp